Corneal application of SOCS1/3 peptides for the treatment of eye diseases mediated by inflammation and oxidative stress.

MLA

Ahmed, Chulbul M., et al. “Corneal Application of SOCS1/3 Peptides for the Treatment of Eye Diseases Mediated by Inflammation and Oxidative Stress.” Frontiers in Immunology, vol. 15, July 2024, p. 1416181. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1416181.

APA

Ahmed, C. M., Johnson, H. M., & Lewin, A. S. (2024). Corneal application of SOCS1/3 peptides for the treatment of eye diseases mediated by inflammation and oxidative stress. Frontiers in Immunology, 15, 1416181. https://doi.org/10.3389/fimmu.2024.1416181

Chicago

Ahmed, Chulbul M, Howard M Johnson, and Alfred S Lewin. 2024. “Corneal Application of SOCS1/3 Peptides for the Treatment of Eye Diseases Mediated by Inflammation and Oxidative Stress.” Frontiers in Immunology 15 (July): 1416181. doi:10.3389/fimmu.2024.1416181.